Abstract:BACKGROUND: DOK3 (Downstream of kinase 3) is involved primarily with immune cell infiltration. Recent research reported the role of DOK3 in tumor progression, with opposite effects in lung cancer and gliomas; however, its role in prostate cancer (PCa) remains elusive. This study aimed to explore the role of DOK3 in PCa and to determine the mechanisms involved.METHODS: To investigate the functions and mechanisms of DOK3 in PCa, we performed bioinformatic and biofunctional analyses. Samples from patients with PCa were collected from West China Hospital, and 46 were selected for the final correlation analysis. A lentivirus-based short hairpin ribonucleic acid (shRNA) carrier was established for silencing DOK3. A series of experiments involving the cell counting kit-8, bromodeoxyuridine, and flow cytometry assays were performed to identify cell proliferation and apoptosis. Changes in biomarkers from the nuclear factor kappa B (NF-κB) signaling pathway were detected to verify the relationship between DOK3 and the NF-κB pathway. A subcutaneous xenograft mouse model was performed to examine phenotypes after knocking down DOK3 in vivo . Rescue experiments with DOK3 knockdown and NF-κB pathway activation were designed to verify regulating effects.RESULTS: DOK3 was up-regulated in PCa cell lines and tissues. In addition, a high level of DOK3 was predictive of higher pathological stages and worse prognoses. Similar results were observed with PCa patient samples. After silencing DOK3 in PCa cell lines 22RV1 and PC3, cell proliferation was significantly inhibited while apoptosis was promoted. Gene set enrichment analysis revealed that DOK3 function was enriched in the NF-κB pathway. Mechanism experiments determined that knockdown of DOK3 suppressed activation of the NF-κB pathway, increased the expressions of B-cell lymphoma-2 like 11 (BIM) and B-cell lymphoma-2 associated X (BAX), and decreased the expression of phosphorylated-P65 and X-linked inhibitor of apoptosis (XIAP). In the rescue experiments, pharmacological activation of NF-κB by tumor necrosis factor-α (TNF-α) partially recovered cell proliferation after the knockdown of DOK3.CONCLUSION: Our findings suggest that overexpression of DOK3 promotes PCa progression by activating the NF-κB signaling pathway.

Knockdown of REGγ Inhibits Proliferation by Inducing Apoptosis and Cell Cycle Arrest in Prostate Cancer.

CRABP2 Promotes Cell Migration and Invasion by Activating PI3K/AKT and MAPK Signalling Pathways Via Upregulating LAMB3 in Prostate Cancer

Nkx3.1 and P27kip1cooperate in Proliferation Inhibition and Apoptosis Induction in Human Androgen–Independent Prostate Cancer Cells

Nonconserved Mir‐608 Suppresses Prostate Cancer Progression Through RAC2/PAK4/LIMK1 and BCL2L1/caspase‐3 Pathways by Targeting the 3′‐utrs of RAC2/BCL2L1 and the Coding Region of PAK4

USP54 is a potential therapeutic target in castration-resistant prostate cancer

Knockdown of prostaglandin reductase 1 (PTGR1) suppresses prostate cancer cell proliferation by inducing cell cycle arrest and apoptosis.

Knockdown of GSG2 Inhibits Prostate Cancer Progressionin Vitroandin Vivo

PPARγ2 Functions As a Tumor Suppressor in a Translational Mouse Model of Human Prostate Cancer

Cyclin-dependent Kinase Inhibitor 3 (CDKN3) Plays a Critical Role in Prostate Cancer Via Regulating Cell Cycle and DNA Replication Signaling

STK10 Knockout Inhibits Cell Migration and Promotes Cell Proliferation Via Modulating the Activity of ERM and P38 MAPK in Prostate Cancer Cells.

Knockdown of REGγ Inhibits the Proliferation and Migration and Promotes the Apoptosis of Multiple Myeloma Cells by Downregulating NF-κB Signal Pathway

Downregulation of CDCA5 Can Inhibit Cell Proliferation, Migration, and Invasion, and Induce Apoptosis of Prostate Cancer Cells

Reg Gamma Deficiency Suppresses Tumor Progression Via Stabilizing Ck1 Epsilon In Renal Cell Carcinoma

REGγ deficiency suppresses tumor progression via stabilizing CK1ε in renal cell carcinoma

DOK3 promotes proliferation and inhibits apoptosis of prostate cancer via the NF-κB signaling pathway

MiR-29a Suppresses Prostate Cell Proliferation and Induces Apoptosis Via KDM5B Protein Regulation.

Knockdown of Zinc Finger Protein X-linked Inhibits Prostate Cancer Cell Proliferation and Induces Apoptosis by Activating Caspase-3 and Caspase-9

TRIM47 silencing inhibits the malignant biological behaviors of prostate cancer cells by regulating MDM2/p53 signaling

Inhibition Of Ezh2 By Chemo- And Radiotherapy Agents And Small Molecule Inhibitors Induces Cell Death In Castration-Resistant Prostate Cancer

c-Jun Transcriptional Regulates NPRL2 to Promote the Proliferation Activity of Prostate Cancer Cells via AKT/MDM2/p53 Signaling Pathway

Targeting POH1 Inhibits Prostate Cancer Cell Growth and Enhances the Suppressive Efficacy of Androgen Deprivation and Docetaxel.